246 related articles for article (PubMed ID: 27036022)
1. The phosphatase of regenerating liver-3 (PRL-3) is important for IL-6-mediated survival of myeloma cells.
Slørdahl TS; Abdollahi P; Vandsemb EN; Rampa C; Misund K; Baranowska KA; Westhrin M; Waage A; Rø TB; Børset M
Oncotarget; 2016 May; 7(19):27295-306. PubMed ID: 27036022
[TBL] [Abstract][Full Text] [Related]
2. IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma.
Chong PSY; Zhou J; Lim JSL; Hee YT; Chooi JY; Chung TH; Tan ZT; Zeng Q; Waller DD; Sebag M; Chng WJ
Cancer Res; 2019 Sep; 79(18):4679-4688. PubMed ID: 31337650
[TBL] [Abstract][Full Text] [Related]
3. Src Family Kinases Are Regulated in Multiple Myeloma Cells by Phosphatase of Regenerating Liver-3.
Abdollahi P; Vandsemb EN; Hjort MA; Misund K; Holien T; Sponaas AM; Rø TB; Slørdahl TS; Børset M
Mol Cancer Res; 2017 Jan; 15(1):69-77. PubMed ID: 27698077
[TBL] [Abstract][Full Text] [Related]
4. Serum/glucocorticoid-regulated kinase 1 (SGK1) is a prominent target gene of the transcriptional response to cytokines in multiple myeloma and supports the growth of myeloma cells.
Fagerli UM; Ullrich K; Stühmer T; Holien T; Köchert K; Holt RU; Bruland O; Chatterjee M; Nogai H; Lenz G; Shaughnessy JD; Mathas S; Sundan A; Bargou RC; Dörken B; Børset M; Janz M
Oncogene; 2011 Jul; 30(28):3198-206. PubMed ID: 21478911
[TBL] [Abstract][Full Text] [Related]
5. Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phosphatase PTEN.
Heo JY; Kim HJ; Kim SM; Park KR; Park SY; Kim SW; Nam D; Jang HJ; Lee SG; Ahn KS; Kim SH; Shim BS; Choi SH; Ahn KS
Cancer Lett; 2011 Sep; 308(1):71-80. PubMed ID: 21565443
[TBL] [Abstract][Full Text] [Related]
6. Overexpression and involvement in migration by the metastasis-associated phosphatase PRL-3 in human myeloma cells.
Fagerli UM; Holt RU; Holien T; Vaatsveen TK; Zhan F; Egeberg KW; Barlogie B; Waage A; Aarset H; Dai HY; Shaughnessy JD; Sundan A; Børset M
Blood; 2008 Jan; 111(2):806-15. PubMed ID: 17934070
[TBL] [Abstract][Full Text] [Related]
7. Phosphatase of regenerating liver-3 is regulated by signal transducer and activator of transcription 3 in acute myeloid leukemia.
Zhou J; Chong PS; Lu X; Cheong LL; Bi C; Liu SC; Zhou Y; Tan TZ; Yang H; Chung TH; Zeng Q; Chng WJ
Exp Hematol; 2014 Dec; 42(12):1041-52.e1-2. PubMed ID: 25139404
[TBL] [Abstract][Full Text] [Related]
8. Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells.
Pedranzini L; Dechow T; Berishaj M; Comenzo R; Zhou P; Azare J; Bornmann W; Bromberg J
Cancer Res; 2006 Oct; 66(19):9714-21. PubMed ID: 17018630
[TBL] [Abstract][Full Text] [Related]
9. In the presence of bone marrow stromal cells human multiple myeloma cells become independent of the IL-6/gp130/STAT3 pathway.
Chatterjee M; Hönemann D; Lentzsch S; Bommert K; Sers C; Herrmann P; Mathas S; Dörken B; Bargou RC
Blood; 2002 Nov; 100(9):3311-8. PubMed ID: 12384432
[TBL] [Abstract][Full Text] [Related]
10. Emodin has a cytotoxic activity against human multiple myeloma as a Janus-activated kinase 2 inhibitor.
Muto A; Hori M; Sasaki Y; Saitoh A; Yasuda I; Maekawa T; Uchida T; Asakura K; Nakazato T; Kaneda T; Kizaki M; Ikeda Y; Yoshida T
Mol Cancer Ther; 2007 Mar; 6(3):987-94. PubMed ID: 17363492
[TBL] [Abstract][Full Text] [Related]
11. Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells.
Bauer K; Kretzschmar AK; Cvijic H; Blumert C; Löffler D; Brocke-Heidrich K; Schiene-Fischer C; Fischer G; Sinz A; Clevenger CV; Horn F
Oncogene; 2009 Aug; 28(31):2784-95. PubMed ID: 19503092
[TBL] [Abstract][Full Text] [Related]
12. PRL-3 induces a positive signaling circuit between glycolysis and activation of STAT1/2.
Vandsemb EN; Rye MB; Steiro IJ; Elsaadi S; Rø TB; Slørdahl TS; Sponaas AM; Børset M; Abdollahi P
FEBS J; 2021 Dec; 288(23):6700-6715. PubMed ID: 34092011
[TBL] [Abstract][Full Text] [Related]
13. INCB16562, a JAK1/2 selective inhibitor, is efficacious against multiple myeloma cells and reverses the protective effects of cytokine and stromal cell support.
Li J; Favata M; Kelley JA; Caulder E; Thomas B; Wen X; Sparks RB; Arvanitis A; Rogers JD; Combs AP; Vaddi K; Solomon KA; Scherle PA; Newton R; Fridman JS
Neoplasia; 2010 Jan; 12(1):28-38. PubMed ID: 20072651
[TBL] [Abstract][Full Text] [Related]
14. Elevated phosphatase of regenerating liver 3 (PRL-3) promotes cytoskeleton reorganization, cell migration and invasion in endometrial stromal cells from endometrioma.
Zhan H; Ma J; Ruan F; Bedaiwy MA; Peng B; Wu R; Lin J
Hum Reprod; 2016 Apr; 31(4):723-33. PubMed ID: 26874360
[TBL] [Abstract][Full Text] [Related]
15. PRL-3 exerts oncogenic functions in myeloid leukemia cells via aberrant dephosphorylation of stathmin and activation of STAT3 signaling.
Xu J; Wu W; Tang Y; Lin Y; Xue Y; Hu J; Lin D
Aging (Albany NY); 2019 Sep; 11(18):7817-7829. PubMed ID: 31546234
[TBL] [Abstract][Full Text] [Related]
16. The serine/threonine kinase Pim-2 is a novel anti-apoptotic mediator in myeloma cells.
Asano J; Nakano A; Oda A; Amou H; Hiasa M; Takeuchi K; Miki H; Nakamura S; Harada T; Fujii S; Kagawa K; Endo I; Yata K; Sakai A; Ozaki S; Matsumoto T; Abe M
Leukemia; 2011 Jul; 25(7):1182-8. PubMed ID: 21475253
[TBL] [Abstract][Full Text] [Related]
17. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1.
Jourdan M; De Vos J; Mechti N; Klein B
Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-6-dependent gene expression profiles in multiple myeloma INA-6 cells reveal a Bcl-2 family-independent survival pathway closely associated with Stat3 activation.
Brocke-Heidrich K; Kretzschmar AK; Pfeifer G; Henze C; Löffler D; Koczan D; Thiesen HJ; Burger R; Gramatzki M; Horn F
Blood; 2004 Jan; 103(1):242-51. PubMed ID: 12969979
[TBL] [Abstract][Full Text] [Related]
19. Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells.
Cheung WC; Van Ness B
Leukemia; 2002 Jun; 16(6):1182-8. PubMed ID: 12040451
[TBL] [Abstract][Full Text] [Related]
20. Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells.
Puthier D; Derenne S; Barillé S; Moreau P; Harousseau JL; Bataille R; Amiot M
Br J Haematol; 1999 Nov; 107(2):392-5. PubMed ID: 10583232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
